BioDiscovery Initiates Software Donation Program to Benefit Pediatric Research
News Jan 07, 2013
BioDiscovery, Inc. has recently launched a new software donation program to assist scientists and benefit pediatric research.
The program is aimed towards those researchers with limited resources but promising projects that will advance diagnosis and treatment of pediatric diseases.
BioDiscovery provides software solutions and services for DNA copy number, gene and miRNA expression, and methylation analysis from microarray and next-generation sequencing (NGS) technologies.
“We are really excited to be able to fund this new program to assist promising young scientists make advances in pediatric research,” said Dr. Soheil Shams, President of BioDiscovery, Inc.
Dr. Shams continued, “We know there are brilliant researchers especially those just starting their careers who have great ideas and projects but may not yet have the funds to move forward with their research. We recognize the heartache children and their families face when afflicted with a disease. Many disorders don’t have any treatment options and some cannot even be diagnosed. We believe that limitations on funding should not be an impediment in finding better treatments, especially for pediatric maladies.”
BioDiscovery has allocated $100,000 worth of software licenses per year that it will be donating to eligible researchers working on pediatric diseases.
Those interested can view the requirements and fill out the application form on the BioDiscovery website. BioDiscovery’s software solutions are designed for the end-user scientist for visualization and analysis of genomic data from aCGH, SNP, methylation and gene/miRNA expression microarrays as well as from NGS technologies.
BioDiscovery’s software is platform independent and available for Mac OS X, Linux and Windows operating systems. BioDiscovery Nexus Copy Number is the leading platform independent and user friendly application for DNA copy number analysis.
Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, Next-Gen read depth, as well as custom arrays.
With its free access to a web-based repository for querying, and storing genomic data from any location across the globe, Nexus Copy Number is a powerful solution for large groups such as special consortia and collaborative research networks.
Nexus Expression is a complete package for analysis and visualization of gene and microRNA expression array data to identify differentially regulated probes, cluster samples and probes and identify common biological themes through gene set enrichment.
ImaGene is recognized by industry experts as the most complete solution for array image analysis with the highest quality results and the easiest to use microarray analysis user interface.
With single click automation, integrated advanced quality control parameters, numerous patented segmentation and contamination removal algorithms, and hundreds of active customers worldwide, ImaGene remains the leader in microarray image analysis.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.